BioCentury | Nov 14, 2020
Management Tracks

Legend’s new look at the top; plus VC moves at Medicxi, OSI and Qiming

...He was SVP and chief legal officer at Q-State Biosciences...
BioCentury | Oct 6, 2020
Management Tracks

BioMarin, Sanofi tap new execs for early R&D positions

...PKU and neuronal ceroid lipofuscinosis type 2 (CLN2).Eggan is a co-founder of at least three biotechs: Q-State Biosciences Inc....
BioCentury | May 16, 2020
Targets & Mechanisms

Gut microbiome manipulation reduces ALS, frontotemporal dementia symptoms

...the inflammatory and autoimmune symptoms. Eggan, a Harvard professor, is a co-founder of neurology companies Q-State Biosciences Inc....
BioCentury | Nov 23, 2019
Politics, Policy & Law

Debating the fate of innovation

No one believes that H.R. 3, the Democratic House leadership’s drug pricing bill, will be enacted into law , but that hasn’t stopped it from precipitating frenzied debates. The bill has become a strawman for advocates...
BioCentury | Sep 30, 2019
Company News

Sept. 30 Company Quick Takes: Lumos-NewLink, Simcere-JW, Ocugen-CanSino, Chamishi’s launch, and AbbVie-Allergan

...oligonucleotide therapy for Parkinson's disease patients carrying a mutation in GBA, Chamishi Therapeutics launched from Q-State Biosciences Inc....
...nuclear receptor subfamily 3 group E member 3 BioCentury Staff AbbVie Inc. Allergan Inc. Simcere Pharmaceutical Group JW Pharmaceutical Corp. Q-State Biosciences Inc. CanSino...
BioCentury | May 25, 2017
Emerging Company Profile

Total reprogramming

...9-15 months to enlarge its product portfolio and scale up manufacturing. At least two companies, Q-State Biosciences Inc....
...CEO: Mark Kotter Patents: None issued Companies and Institutions Mentioned Elpis Biomed Ltd., Histon, U.K. Q-State Biosciences Inc....
...into neurons, skeletal myocytes, and oligodendrocytes." Stem Cell Reports (2017) Karen Tkach Tuzman, Senior Writer Elpis Biomed Ltd. Q-State Biosciences Inc. Myogenic...
BioCentury | Apr 14, 2017
Company News

UCB, Q-State deal

...to disclose financial details. Q-State Biosciences Inc. , Cambridge, Mass. UCB Group (Euronext:UCB), Brussels, Belgium Business: Neurology Julian Zhu Q-State Biosciences Inc. UCB...
BioCentury | Nov 4, 2016
Strategy

The next (re)generation

...said disease-in-a-dish models had predicted effects correctly in control individuals, and noted that he co-founded Q-State Biosciences Inc....
...General Hospital, Boston, Mass. Microbot Medical Ltd., Yokneam, Israel Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Q-State Biosciences Inc....
BioCentury | Jun 25, 2015
Emerging Company Profile

Light-speed electrophysiology

...of cells simultaneously has hampered the development of new therapies for neurological and cardiac diseases. Q-State Biosciences Inc....
...round. Companies and Institutions Mentioned GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Harvard University, Cambridge, Mass. Q-State Biosciences Inc....
...al. "Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons." Cell Reports (2014) Sidebars Q-State Biosciences Inc....
BioCentury | Oct 10, 2009
Politics & Policy

Quebec, Kansas unveil financing for life sciences

Quebec announced the Quebec Biopharmaceutical Strategy , a program to provide development support for biotech and biopharmaceutical companies in the province. The government is providing C$122.8 million ($114 million) to fund the program. Separately, the Kansas...
Items per page:
1 - 10 of 11
BioCentury | Nov 14, 2020
Management Tracks

Legend’s new look at the top; plus VC moves at Medicxi, OSI and Qiming

...He was SVP and chief legal officer at Q-State Biosciences...
BioCentury | Oct 6, 2020
Management Tracks

BioMarin, Sanofi tap new execs for early R&D positions

...PKU and neuronal ceroid lipofuscinosis type 2 (CLN2).Eggan is a co-founder of at least three biotechs: Q-State Biosciences Inc....
BioCentury | May 16, 2020
Targets & Mechanisms

Gut microbiome manipulation reduces ALS, frontotemporal dementia symptoms

...the inflammatory and autoimmune symptoms. Eggan, a Harvard professor, is a co-founder of neurology companies Q-State Biosciences Inc....
BioCentury | Nov 23, 2019
Politics, Policy & Law

Debating the fate of innovation

No one believes that H.R. 3, the Democratic House leadership’s drug pricing bill, will be enacted into law , but that hasn’t stopped it from precipitating frenzied debates. The bill has become a strawman for advocates...
BioCentury | Sep 30, 2019
Company News

Sept. 30 Company Quick Takes: Lumos-NewLink, Simcere-JW, Ocugen-CanSino, Chamishi’s launch, and AbbVie-Allergan

...oligonucleotide therapy for Parkinson's disease patients carrying a mutation in GBA, Chamishi Therapeutics launched from Q-State Biosciences Inc....
...nuclear receptor subfamily 3 group E member 3 BioCentury Staff AbbVie Inc. Allergan Inc. Simcere Pharmaceutical Group JW Pharmaceutical Corp. Q-State Biosciences Inc. CanSino...
BioCentury | May 25, 2017
Emerging Company Profile

Total reprogramming

...9-15 months to enlarge its product portfolio and scale up manufacturing. At least two companies, Q-State Biosciences Inc....
...CEO: Mark Kotter Patents: None issued Companies and Institutions Mentioned Elpis Biomed Ltd., Histon, U.K. Q-State Biosciences Inc....
...into neurons, skeletal myocytes, and oligodendrocytes." Stem Cell Reports (2017) Karen Tkach Tuzman, Senior Writer Elpis Biomed Ltd. Q-State Biosciences Inc. Myogenic...
BioCentury | Apr 14, 2017
Company News

UCB, Q-State deal

...to disclose financial details. Q-State Biosciences Inc. , Cambridge, Mass. UCB Group (Euronext:UCB), Brussels, Belgium Business: Neurology Julian Zhu Q-State Biosciences Inc. UCB...
BioCentury | Nov 4, 2016
Strategy

The next (re)generation

...said disease-in-a-dish models had predicted effects correctly in control individuals, and noted that he co-founded Q-State Biosciences Inc....
...General Hospital, Boston, Mass. Microbot Medical Ltd., Yokneam, Israel Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Q-State Biosciences Inc....
BioCentury | Jun 25, 2015
Emerging Company Profile

Light-speed electrophysiology

...of cells simultaneously has hampered the development of new therapies for neurological and cardiac diseases. Q-State Biosciences Inc....
...round. Companies and Institutions Mentioned GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Harvard University, Cambridge, Mass. Q-State Biosciences Inc....
...al. "Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons." Cell Reports (2014) Sidebars Q-State Biosciences Inc....
BioCentury | Oct 10, 2009
Politics & Policy

Quebec, Kansas unveil financing for life sciences

Quebec announced the Quebec Biopharmaceutical Strategy , a program to provide development support for biotech and biopharmaceutical companies in the province. The government is providing C$122.8 million ($114 million) to fund the program. Separately, the Kansas...
Items per page:
1 - 10 of 11